Allergan, manufacturer of products such as silicon and saline breast implants and Botox, may have scored a remarkable lobbying victory which will likely make it the hero of its industry. The company has been an outspoken opponent of the proposal in the Senate healthcare reform ...
Clinica
Allergan scores tax victory for cosmetic surgery industry
22 December 2009
Peter Rixon
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- US appeals court rules in favour of BRCA gene patenting
- Rebranded PIP breast implants – many women in UK and other countries "unaware" of risks
- Latest EU directive revision details: medtech reg to take on aesthetic implantables and invasive products?
- Delay likely for EU medtech directive recast draft as proposed revisions undergo stress testing
Other Informa News
Features & Analysis
Other Informa Analysis
EVENTS
19 March 2012
Montreux Convention and Music Centre, Switzerland
